Dr. Leigh Beveridge is a physician-scientist and biotechnology leader whose career spans hematology, oncology, and immunology. With over a decade of experience across academic medicine and global clinical development, Dr. Beveridge has led late-stage programs that shape the future of patient care. Most recently, he served as Lead Medical Director at Genentech, overseeing pivotal trials in hematologic diseases and complement inhibition. Prior to that, he directed global development at Servier, advancing therapies for leukemia and guiding regulatory filings and pediatric extensions. Rooted in a background in hematology and internal medicine, Dr. Beveridge combines scientific rigor with patient-centered innovation—bridging research, regulation, and compassionate care.